Atrás
También listada como
OTSKY
OTC
Rango del Día
$69.59
$69.59
Rango de 52 Semanas
$44.40
$70.34
Volumen
212
Promedio 50D / 200D
$57.93
/
$52.15
Cierre Anterior
$70.34
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 0.1 | 0.4 |
| P/B | 0.0 | 2.9 |
| ROE % | 12.6 | 3.8 |
| Net Margin % | 14.7 | 3.9 |
| Rev Growth 5Y % | 13.3 | 10.0 |
| D/E | 0.1 | 0.2 |
Puntos Clave
Revenue grew 13.32% annually over 5 years — strong growth
ROE of 12.60% — decent returns on equity
Debt/Equity of 0.10 — conservative balance sheet
Generating 316.01B in free cash flow
P/E of 0.10 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 7.26%
Crecimiento
Revenue Growth (5Y)
13.32%
Revenue (1Y)6.06%
Earnings (1Y)5.93%
FCF Growth (3Y)36.92%
Calidad
Return on Equity
12.60%
ROIC9.26%
Net Margin14.71%
Op. Margin16.71%
Seguridad
Debt / Equity
0.10
Current Ratio2.17
Interest Coverage15.26
Valoración
P/E Ratio
0.10
P/B Ratio0.01
EV/EBITDA-0.46
Dividend Yield0.02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 6.06% | Revenue Growth (3Y) | 10.64% |
| Earnings Growth (1Y) | 5.93% | Earnings Growth (3Y) | 72.88% |
| Revenue Growth (5Y) | 13.32% | Earnings Growth (5Y) | 30.46% |
| Profitability | |||
| Revenue (TTM) | 2.47T | Net Income (TTM) | 363.47B |
| ROE | 12.60% | ROA | 8.65% |
| Gross Margin | 71.68% | Operating Margin | 16.71% |
| Net Margin | 14.71% | Free Cash Flow (TTM) | 316.01B |
| ROIC | 9.26% | FCF Growth (3Y) | 36.92% |
| Safety | |||
| Debt / Equity | 0.10 | Current Ratio | 2.17 |
| Interest Coverage | 15.26 | Dividend Yield | 0.02% |
| Valuation | |||
| P/E Ratio | 0.10 | P/B Ratio | 0.01 |
| P/S Ratio | 0.01 | PEG Ratio | 1.52 |
| EV/EBITDA | -0.46 | Dividend Yield | 0.02% |
| Market Cap | 36.75B | Enterprise Value | -191.05B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2.47T | 2.33T | 2.02T | 1.74T | 1.50T |
| Net Income | 363.47B | 343.12B | 121.62B | 133.91B | 125.46B |
| EPS (Diluted) | 685.44 | 633.77 | 224.10 | 246.79 | 231.15 |
| Gross Profit | 1.77T | 1.67T | 1.41T | 1.17T | 1.00T |
| Operating Income | 412.79B | 323.56B | 139.61B | 150.32B | 154.50B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 4.20T | 3.74T | 3.36T | 3.10T | 2.82T |
| Total Liabilities | 1.10T | 961.09B | 924.93B | 840.17B | 775.73B |
| Shareholders' Equity | 3.04T | 2.73T | 2.39T | 2.23T | 2.01T |
| Total Debt | 307.31B | 189.38B | 214.19B | 194.16B | 212.45B |
| Cash & Equivalents | 535.11B | 426.17B | 513.34B | 471.63B | 410.68B |
| Current Assets | 1.62T | 1.37T | 1.33T | 1.19T | 1.05T |
| Current Liabilities | 749.77B | 632.66B | 667.23B | 539.19B | 467.91B |
Puntuaciones de Estrategias
This stock passed the criteria for 4 strategies
Score = fit strength (0–100)
Rank = position among all matches
Actividad Reciente
Entró
Cash Flow Compounder
Mar 24, 2026
Entró
Deep Value Investing (Seth Klarman)
Mar 24, 2026
Entró
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026
Entró
Defensive Investing (Benjamin Graham)
Mar 24, 2026